The cancer COMPASS: navigating the functions of MLL complexes in cancer

Cancer Genetics
David J Ford, Andrew K Dingwall

Abstract

The mixed-lineage leukemia family of histone methyltransferases (MLL1-4, or KMT2A-D) were previously linked to cancer through the founding member, MLL1/KMT2A, which is often involved in translocation-associated gene fusion events in childhood leukemias. However, in recent years, a multitude of tumor exome sequencing studies have revealed that orthologues MLL3/KMT2C and MLL2/KMT2D are mutated in a significant percentage of a large variety of malignancies, particularly solid tumors. These unexpected findings necessitate a deeper inspection into the activities and functional differences between the MLL/KMT2 family members. This review provides an overview of this protein family and its relation to cancers, focusing on the recent links between MLL3/KMT2C and MLL2/4/KMT2D and their potential roles as tumor suppressors in an assortment of cell types.

References

Dec 11, 1991·Proceedings of the National Academy of Sciences of the United States of America·S Ziemin-van der PoelJ D Rowley
Jan 19, 2000·Nature·B D Strahl, C D Allis
Mar 15, 2002·Current Opinion in Genetics & Development·Jeffrey A Simon, John W Tamkun
Oct 9, 2002·The Journal of Biological Chemistry·Shao-Qing KuangJianming Xu
Oct 11, 2002·Nature·Sooryanarayana VaramballyArul M Chinnaiyan
Jan 31, 2003·Molecular and Cellular Biology·Per AntonsonJan-Ake Gustafsson
Sep 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Celina G KleerArul M Chinnaiyan
Mar 20, 2004·Developmental Cell·Patricia ErnstStanley J Korsmeyer
Oct 6, 2006·Proceedings of the National Academy of Sciences of the United States of America·Seunghee LeeJae W Lee
Oct 25, 2006·Nature Reviews. Cancer·Anke Sparmann, Maarten van Lohuizen
Feb 27, 2007·Cell·Bernd SchuettengruberGiacomo Cavalli
Mar 16, 2007·The Journal of Biological Chemistry·Jeong-Heon LeeDavid G Skalnik
Apr 13, 2007·Molecular Biology of the Cell·Sandra LubitzKonstantinos Anastassiadis
May 15, 2007·The Journal of Biological Chemistry·Young-Wook ChoKai Ge
Oct 11, 2007·Developmental Cell·Sanjeevkumar R PatelGregory R Dressler
Nov 21, 2007·Cell·C David AllisYi Zhang
Aug 30, 2008·Mutation Research·Jeffrey A Simon, Carol A Lange
Dec 3, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jeongkyung LeeJae W Lee
Jan 21, 2009·Cell Research·Jian RenXuebiao Yao
May 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jeongkyung LeeJae W Lee
Feb 4, 2010·PloS One·Hassan AshktorabHassan Brim
May 11, 2010·Journal of Molecular Biology·Pei-Yun ChangMichael L Cleary
May 11, 2010·International Journal of Hematology·Tim C P Somervaille, Michael L Cleary
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Sep 9, 2010·International Journal of Cancer. Journal International Du Cancer·Nara ShinHoguen Kim
Dec 1, 2010·Pathology Oncology Research : POR·Xin-Xin WangJin-Tang Dong
Dec 18, 2010·Science·D Williams ParsonsVictor E Velculescu
Jan 29, 2011·Journal of Molecular Biology·Kathryn E GardnerBrian D Strahl
Mar 29, 2011·Chinese Journal of Cancer·Min Wu, Hong-Bing Shu
Jul 30, 2011·Science·Nicolas StranskyJennifer R Grandis
Aug 31, 2011·Molecular and Cellular Biology·Man MohanAli Shilatifard

❮ Previous
Next ❯

Citations

Feb 24, 2016·American Journal of Medical Genetics. Part a·Paraskevi KaragianniIoannis Spyridakis
Sep 4, 2015·Nature·Carol Prives, Scott W Lowe
Jan 23, 2016·American Journal of Hematology·Damien Roos-WeilOlivier A Bernard
May 24, 2016·International Journal of Molecular Sciences·Mckenna LongacreSibaji Sarkar
Jul 14, 2016·Epigenomics·Dashzeveg Bayarsaihan
Dec 21, 2016·International Journal of Cancer. Journal International Du Cancer·Pablo García-SanzGema Moreno-Bueno
Feb 6, 2017·Protein Science : a Publication of the Protein Society·Masoud VedadiTaraneh Hajian
Jun 2, 2017·Nature Reviews. Disease Primers·Jaffer A AjaniShumei Song
Apr 5, 2017·Current Opinion in Hematology·Weiwei Yang, Patricia Ernst
Jul 21, 2017·Cell Death & Disease·Changlin ZhangWuguo Deng
Feb 10, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Melanie JohncillaAmitabh Srivastava
Nov 22, 2018·Journal of Human Genetics·Víctor FaundesSiddharth Banka
Jan 11, 2019·International Journal of Cancer. Journal International Du Cancer·Wolfgang A SchulzAnnemarie Greife
Dec 28, 2017·Nature Reviews. Genetics·Vineet K DhimanKevin P White
Apr 26, 2019·The American Journal of Surgical Pathology·Naser M AliFarida Latif
Nov 9, 2017·Oncotarget·Caterina ChiappettaClaudio Di Cristofano
Feb 15, 2018·Genes & Development·Enrique Lin-ShiaoBrian C Capell
Jun 30, 2019·Nature Communications·Ken TajimaShyamala Maheswaran
Nov 23, 2019·Breast Cancer Research : BCR·Simona PunziLuisa Lanfrancone
Aug 28, 2020·Frontiers in Cell and Developmental Biology·Ashley JannaJean-Francois Couture
Nov 21, 2018·Life Science Alliance·Donghang ChengMark T Bedford
Aug 2, 2019·Genes, Chromosomes & Cancer·Julie A I ThomsJohn E Pimanda
Aug 23, 2019·World Journal of Gastrointestinal Oncology·Si-Si LiRong Wan
Jul 8, 2020·International Journal of Molecular Sciences·Joan Serrano-QuílezSusana Rodríguez-Navarro
Nov 9, 2020·Clinical Epigenetics·Ping Zhang, Mingzhi Zhang
Mar 21, 2020·Cancer Discovery·Hitomi SakamotoChristine A Iacobuzio-Donahue
Jun 25, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hyunseok KangNishant Agrawal
Feb 13, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kohei KobatakeHiroaki Honda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

The American Journal of Nursing
Devin Katrina Smith
Mammalian Genome : Official Journal of the International Mammalian Genome Society
M PravenecE St Lezin
Future Oncology
Christian Bach, Robert K Slany
© 2021 Meta ULC. All rights reserved